WBA Walgreens Boots Alliance (NASDAQ) $11.98 pre-market 26 Mar 2026: heavy volume

WBA stock is trading at $11.98 in the pre-market on 26 Mar 2026, with unusually large activity after the open. The session shows 452,081,061.00 shares traded vs an average of 16,940,296.00, putting Walgreens Boots Alliance, Inc. (NASDAQ) at the top of most-active lists in the United States. This note highlights valuation, liquidity, catalyst risk, and short-interest context to explain why traders are focused on WBA stock today.

Price, volume and immediate market context for WBA stock

WBA stock opened pre-market at $11.98 following a prior close of $11.92. Volume is 452,081,061.00, outpacing the average volume of 16,940,296.00 and producing a relative volume of 26.69. One clear claim: heavy trading increases intraday volatility and widens bid-ask spreads for WBA stock.

Valuation snapshot and key ratios for Walgreens Boots Alliance

Walgreens Boots Alliance shows a price-to-book of 1.44 and price-to-sales of 0.09, indicating low market valuation versus book and revenue. One claim: negative EPS of -7.29 and PE of -1.64 reflect recent losses and make earnings multiples unreliable for WBA stock valuation.

Balance sheet, cash flow and dividend signals

WBA’s debt-to-equity is 4.04 and current ratio is 0.60, pointing to leverage and tight near-term liquidity. One claim: the company pays a dividend of $0.25 per share (yield 2.09%) but free cash flow per share is -0.59, implying coverage risk for the dividend if cash flows do not recover.

Technicals, momentum and trading setup for most-active traders

Short-term indicators show strong momentum: 50-day average is 11.66 and 200-day average is 10.81, with ADX reading 50.00 indicating a strong trend. One claim: elevated on‑book volume (OBV 452,081,061.00) supports aggressive short-term trading interest in WBA stock.

Meyka AI grade, analyst context and price targets

Meyka AI rates WBA with a score out of 100: 59.36 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. One claim: analyst consensus skew is limited (consensus score 2.00 from upgrade/downgrade data), so third-party price targets are sparse. Suggested practical price targets: conservative $10.00 (‑16.53%), base $13.50 (+12.69%), bull $16.00 (+33.56%).

News, short interest and what could move WBA stock next

Recent short-interest reports and market chatter are in focus for WBA stock; MarketBeat shows updated short-interest data that traders watch for squeezes source. One claim: macro health care flow and international revenue signals will move the stock ahead of the next earnings announcement on 25 Jun 2025. For broader market context see related market data from Investing.com source.

Final Thoughts

Key takeaways for WBA stock: the pre-market price $11.98 and extreme volume of 452,081,061.00 show trader focus but not a clear fundamental inflection. Valuation metrics (PB 1.44, P/S 0.09) suggest the market prices Walgreens Boots Alliance for low growth, while leverage (debt/equity 4.04) and negative EPS -7.29 raise solvency concerns. Meyka AI’s forecast model projects a 12-month price of $4.08, implying downside of -65.94% versus the current price of $11.98; forecasts are model-based projections and not guarantees. For traders looking at the most-active setup, pair short-term technical signals with liquidity measures and watch short-interest updates and the next earnings on 25 Jun 2025. Use conservative price targets ($10.00) and a clear stop plan for active trading; long-term investors should weigh the dividend yield 2.09% against recovery risk. This note includes analysis from Meyka AI-powered market analysis platform and is for informational purposes only.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.